High Incidence of MDR and XDR Pseudomonas aeruginosa Isolates Harboring blaGES, blaVEB, and blaPER Extended-Spectrum Beta-Lactamase Genes in Iran

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 201

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-8-4_001

تاریخ نمایه سازی: 29 فروردین 1402

چکیده مقاله:

Aims: The ever-increasing incidence of multidrug resistance in ESBL-producing Pseudomonas aeruginosa is one of the most serious public health threats. This study aimed to investigate the antibiotic resistance profile and molecular characteristics of ESBL-producing P. aeruginosa isolates. Materials & Methods: Antimicrobial susceptibility testing was performed for ۱۲۰ P. aeruginosa clinical isolates using the Kirby-Bauer disk diffusion and broth microdilution assays. Combined disk test (CDT) was applied to screen for ESBL production among P. aeruginosa isolates. PCR assays determined the presence of blaGES, blaPER, and blaVEB genes in all isolates. Findings: The clinical isolates of P. aeruginosa showed the highest resistance to cefotaxime (۸۶.۷%) and gentamicin (۶۵.۸%). Of ۱۲۰ P. aeruginosa isolates, ۶۰.۸% were MDR, and ۵۳.۳% were XDR. The prevalence of these strains was significantly higher in hospitalized patients than in out-patients (p<.۰۰۱). Also, ۵۸ P. aeruginosa strains (۴۸.۳%) were considered as phenotypic ESBL producers. Furthermore, ۱۵, ۳۵, and ۲۴.۲% of P. aeruginosa isolates harbored blaGES, blaVEB, and blaPER, respectively. The incidence of MDR (۷۱.۴% vs. ۴۱.۹%, p= .۰۰۱) and XDR (۶۳.۶% vs. ۳۴.۹%, p= .۰۰۲) was significantly higher in ESBL-producing P. aeruginosa isolates compared to non-ESBL producers. The highest incidence rate of MDR was reported in blaVEB gene-positive P. aeruginosa isolates (۹۵.۲%), followed by isolates harboring blaPER (۷۹.۳%) and blaGES (۵۵.۶%) genes. Conclusion: This study findings show a high prevalence of MDR ESBL-producing P. aeruginosa isolates, indicating the importance of correct identification of these superbugs and judicious use of various antibiotics to prevent their spread.

نویسندگان

Fahimeh Beiki

School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Amir Tavakoli Kareshk

Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

Parvin Askari

Department of Medical Microbiology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Ali Hashemi

Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences,Tehran, Iran.

Masoud Yousefi

Department of Medical Microbiology, School of Medicine, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Spagnolo AM, Sartini M, Cristina ML. Pseudomonas aeruginosa in the ...
  • Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance ...
  • Sharifi H, Pouladfar G, Shakibaie MR, Pourabbas B, Mardaneh J, ...
  • Su TY, Ye JJ, Hsu PC, Wu HF, Chia JH, ...
  • Dehbashi S, Tahmasebi H, Arabestani MR. Association between Beta-lactam Antibiotic ...
  • Anvarinejad M, Japoni A, Rafaatpour N, Mardaneh J, Abbasi P, ...
  • Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, ...
  • Nazari-Alam A, Sarvari J, Motamedifar M, Khoshkharam H, Yousefi M, ...
  • Namaei MH, Yousefi M, Askari P, Roshanravan B, Hashemi A, ...
  • Askari P, Hakimi F, Moghanni M, Sebzari AR, Namaei MH. ...
  • Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: An update ...
  • Laudy AE, Róg P, Smolińska-Król K, Ćmiel M, Słoczyńska A, ...
  • Tawfik AF, Shibl AM, Aljohi MA, Altammami MA, Al-Agamy MH. ...
  • Libisch B, Poirel L, Lepsanovic Z, Mirovic V, Balogh B, ...
  • Wayne PA. Clinical and Laboratory Standards Institute (CLSI). Performance Standards ...
  • Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, ...
  • Lee S, Park YJ, Kim M, Lee HK, Han K, ...
  • Spilker T, Coenye T, Vandamme P, LiPuma JJ. PCR-based assay ...
  • Gupta R, Malik A, Rizvi M, Ahmed M. Presence of ...
  • Farhan SM, Ibrahim RA, Mahran KM, Hetta HF, Abd El-Baky ...
  • Chaudhary A, Bhandari D, Amatya J, Chaudhary P, Acharya B. ...
  • Porbaran M, Habibipour R. Relationship between biofilm regulating operons and ...
  • Pérez A, Gato E, Pérez-Llarena J, Fernández-Cuenca F, Gude MJ, ...
  • El-Far A, Samir S, El-Gebaly E, Omar M, Dahroug H, ...
  • Ali FA, Bakir SH, Haji SH, Hussen BM. Evaluation of ...
  • Shukla SD, Gupta G, Khatoon R, Jain R, Gupta A. ...
  • Del Giacomo P, Raffaelli F, Losito AR, Fiori B, Tumbarello ...
  • Vo T, Bui Q, Nguyen H, Pham H. Antimicrobial Resistance ...
  • Mahto M, Shah A, Show K, Moses F, Stewart A. ...
  • Moroh JL, Fleury Y, Tia H, Bahi C, Lietard C, ...
  • Hashemi NS, Mojiri M, Yazdani Kachouyi P, Eskandari S, Mohammadian ...
  • Sheikh AF, Shahin M, Shokoohizadeh L, Ghanbari F, Solgi H, ...
  • Hosu MC, Vasaikar SD, Okuthe GE, Apalata T. Detection of ...
  • Shiny P, Rajendran S, Sarayu YL. A study on isolation ...
  • Abdelrahman DN, Taha AA, Dafaallah MM, Mohammed AA, El Hussein ...
  • Afunwa RA, Odimegwu DC, Iroha RI, Esimone CO. Antimicrobial resistance ...
  • Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes ...
  • Haghighi S, Goli HR. High prevalence of bla VEB, bla ...
  • Alikhani MY, Tabar ZK, Mihani F, Kalantar E, Karami P, ...
  • Komijani M, Shahin K, Barazandeh M, Sajadi M. Prevalence of ...
  • Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA. ...
  • Shilpakar A, Ansari M, Rai KR, Rai G, Rai SK. ...
  • Nasser M, Ogaili M, Palwe S, Kharat AS. Molecular detection ...
  • نمایش کامل مراجع